ReoPro abciximab: Marketed

CNTO and partner Eli Lilly and Co. announced preliminary 30-day data from the Phase II ADMIRAL (abciximab before direct angioplasty and stenting in myocardial infarction regarding acute and long-term

Read the full 296 word article

How to gain access

Continue reading with a
two-week free trial.